Impedimed (ASX:IPD) Operating Cash Flow per Share : A$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Impedimed Operating Cash Flow per Share?

Impedimed's operating cash flow per share for the six months ended in Dec. 2023 was A$-0.00. Impedimed's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 32.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 34.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Impedimed's Operating Cash Flow per Share or its related term are showing as below:

ASX:IPD' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -26.6 Med: 17.7 Max: 43.2
Current: 32.1

During the past 13 years, Impedimed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 43.20% per year. The lowest was -26.60% per year. And the median was 17.70% per year.

ASX:IPD's 3-Year OCF Growth Rate is ranked better than
83.58% of 682 companies
in the Medical Devices & Instruments industry
Industry Median: 3.65 vs ASX:IPD: 32.10

Impedimed Operating Cash Flow per Share Historical Data

The historical data trend for Impedimed's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Operating Cash Flow per Share Chart

Impedimed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.05

-0.03

-0.01

Impedimed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-0.01	-0.01	-	-

Competitive Comparison of Impedimed's Operating Cash Flow per Share

For the Medical Devices subindustry, Impedimed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impedimed's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Impedimed's Price-to-Operating-Cash-Flow falls into.

Impedimed Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Impedimed's Operating Cash Flow per Share for the fiscal year that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (A: Jun. 2023 )	=	Cash Flow from Operations (A: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (A: Jun. 2023 )
	=	-18.049	/	1800.349
	=	-0.01

Impedimed's Operating Cash Flow per Share for the quarter that ended in Jun. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	-6.774	/	1997.847
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Impedimed Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Impedimed's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Impedimed (ASX:IPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

IPDQF:USA

Address

50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008

Website

https://www.impedimed.com

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Impedimed (ASX:IPD) Headlines

No Headlines